卫光生物 - Financials

卫光生物 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012
+Revenue	1.2B	1.0B	668.0M	907.0M	905.0M	821.0M	688.0M	623.0M	566.0M	501.0M	453.0M	355.0M	300.0M
Revenue Growth %	14.7%	57.0%	-26.4%	0.2%	10.2%	19.3%	10.4%	10.1%	13.0%	10.6%	27.6%	18.3%	--
Total Revenue	1.2B	1.0B	668.0M	907.0M	905.0M	821.0M	688.0M	623.0M	566.0M	501.0M	453.0M	355.0M	300.0M
Cost Of Revenue	699.0M	615.0M	427.0M	537.0M	568.0M	506.0M	414.0M	347.0M	298.0M	268.0M	252.0M	180.0M	155.0M
+Gross Profit	504.0M	434.0M	241.0M	370.0M	337.0M	315.0M	274.0M	276.0M	268.0M	233.0M	201.0M	175.0M	145.0M
Gross Margin %	41.9%	41.4%	36.1%	40.8%	37.2%	38.4%	39.8%	44.3%	47.3%	46.5%	44.4%	49.3%	48.3%
Total Operating Cost	905.0M	823.0M	557.0M	676.0M	693.0M	633.0M	517.0M	452.0M	398.0M	362.0M	342.0M	262.0M	221.0M
Selling Expenses	29.1M	40.9M	27.3M	23.8M	19.7M	24.0M	24.0M	14.4M	12.8M	12.2M	11.3M	11.9M	11.4M
Admin Expenses	92.7M	86.1M	64.4M	64.7M	61.9M	53.1M	45.1M	45.4M	66.5M	54.9M	44.5M	47.3M	43.0M
Rd Expenses	49.1M	63.6M	35.9M	47.6M	45.1M	40.2M	23.7M	25.6M	--	--	--	--	--
Finance Expenses	20.3M	12.5M	-1.5M	-5.8M	-7.2M	-982,100	1.5M	8.6M	17.4M	24.2M	24.5M	19.6M	7.5M
+Operating Income	297.0M	247.0M	138.0M	242.0M	221.0M	199.0M	182.0M	179.0M	169.0M	139.0M	111.0M	93.2M	79.2M
Operating Margin %	24.7%	23.5%	20.7%	26.7%	24.4%	24.2%	26.5%	28.7%	29.9%	27.7%	24.5%	26.2%	26.4%
Non Operating Income	1.1M	331,100	160,600	502,700	666,400	159,300	257,100	2.3M	11.6M	7.1M	7.0M	11.3M	5.3M
Non Operating Expenses	987,700	2.2M	1.0M	1.1M	2.3M	1.0M	434,500	367,900	701,800	512,700	299,100	291,800	1.3M
Investment Income	5.4M	5.2M	4.4M	--	--	--	--	--	--	--	--	--	--
Fair Value Change Income	-14.1M	2.2M	14.3M	736,400	--	--	--	--	--	--	--	--	--
Asset Disposal Income	45,800	--	36,900	--	66,800	49,300	-38,600	38,100	--	--	--	--	--
Asset Impairment Loss	--	--	--	--	--	--	2.0M	5.1M	61,000	48,600	6.0M	79,800	-133,800
Other Income	7.5M	14.2M	8.7M	9.5M	8.6M	10.3M	10.8M	7.5M	--	--	--	--	--
Income Before Tax	297.0M	245.0M	137.0M	241.0M	219.0M	198.0M	182.0M	181.0M	179.0M	146.0M	118.0M	104.0M	83.2M
Income Tax	42.8M	27.9M	16.1M	36.2M	29.5M	27.1M	25.2M	26.0M	26.2M	20.8M	17.3M	15.3M	11.8M
+Net Income	254.0M	218.0M	121.0M	205.0M	190.0M	171.0M	157.0M	155.0M	153.0M	125.0M	101.0M	88.9M	71.4M
Net Margin %	21.1%	20.8%	18.1%	22.6%	21.0%	20.8%	22.8%	24.9%	27.0%	25.0%	22.3%	25.0%	23.8%
Net Income Attributable	254.0M	219.0M	118.0M	205.0M	190.0M	171.0M	157.0M	155.0M	153.0M	125.0M	101.0M	88.9M	71.4M
Minority Interest	440,800	-1.1M	3.7M	-444,400	-813,200	-192,900	--	--	--	--	--	--	--
Eps Basic	1.12	0.96	0.52	0.91	1.18	1.59	1.45	1.64	1.89	1.54	1.24	1.10	0.88
Eps Diluted	1.12	0.96	0.52	0.91	1.18	1.59	1.45	1.64	1.89	1.54	1.24	1.10	0.88

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012
Cash And Equivalents	275.0M	252.0M	295.0M	332.0M	471.0M	305.0M	260.0M	339.0M	61.9M	119.0M	114.0M	70.4M	140.0M
Accounts Receivable	133.0M	55.4M	103.0M	128.0M	107.0M	134.0M	70.6M	49.6M	3.5M	1.8M	2.6M	987,200	297,400
Notes Receivable	151.0M	78.5M	106.0M	75.9M	139.0M	98.5M	96.0M	43.4M	7.0M	1.9M	3.2M	6.5M	2.5M
Notes And Accounts Receivable	284.0M	134.0M	208.0M	204.0M	247.0M	232.0M	167.0M	93.0M	10.5M	3.7M	5.9M	7.5M	2.8M
Prepayments	2.1M	2.1M	12.3M	7.2M	5.3M	3.1M	5.2M	4.0M	4.7M	4.1M	2.2M	4.3M	4.9M
Inventory	793.0M	673.0M	606.0M	422.0M	384.0M	468.0M	496.0M	448.0M	362.0M	277.0M	246.0M	230.0M	153.0M
Total Current Assets	1.5B	1.1B	1.1B	999.0M	1.1B	1.0B	929.0M	884.0M	439.0M	404.0M	368.0M	312.0M	301.0M
Fixed Assets	--	575.0M	491.0M	425.0M	297.0M	205.0M	221.0M	235.0M	258.0M	276.0M	299.0M	315.0M	143.0M
Fixed Assets Total	634.0M	575.0M	491.0M	425.0M	297.0M	205.0M	221.0M	235.0M	258.0M	276.0M	299.0M	315.0M	143.0M
Construction In Progress	--	91.7M	536.0M	342.0M	268.0M	243.0M	204.0M	158.0M	116.0M	76.3M	4.1M	3.8M	139.0M
Construction In Progress Total	42.2M	91.7M	536.0M	342.0M	268.0M	243.0M	204.0M	158.0M	116.0M	76.3M	4.1M	3.8M	139.0M
Intangible Assets	135.0M	137.0M	75.1M	76.3M	78.8M	79.0M	73.2M	75.0M	75.2M	77.2M	77.2M	61.2M	62.1M
Long Term Deferred Expenses	1.9M	3.2M	3.1M	4.7M	4.2M	--	--	--	--	--	--	--	--
Total Non Current Assets	1.8B	1.8B	1.4B	1.0B	714.0M	577.0M	534.0M	490.0M	471.0M	452.0M	402.0M	401.0M	364.0M
Total Assets	3.3B	2.9B	2.6B	2.0B	1.8B	1.6B	1.5B	1.4B	910.0M	856.0M	770.0M	713.0M	666.0M
Short Term Borrowings	100.0M	--	100.0M	25.0M	82.0M	--	5.0M	37.0M	178.0M	220.0M	243.0M	245.0M	155.0M
Accounts Payable	137.0M	77.5M	33.1M	29.0M	24.1M	20.0M	16.3M	9.6M	6.8M	8.2M	8.6M	12.2M	9.1M
Advance Receipts	68,800	67,900	12,300	--	--	1.5M	4.3M	675,500	1.6M	1.1M	2.4M	1.6M	29.5M
Contract Liabilities	759,900	3.2M	7.8M	2.4M	2.6M	--	--	--	--	--	--	--	--
Total Current Liabilities	423.0M	266.0M	230.0M	167.0M	184.0M	103.0M	115.0M	106.0M	273.0M	310.0M	364.0M	321.0M	382.0M
Long Term Borrowings	554.0M	484.0M	429.0M	--	--	--	--	24.0M	76.0M	96.9M	39.4M	112.0M	90.0M
Total Non Current Liabilities	630.0M	565.0M	478.0M	48.1M	27.9M	33.6M	38.0M	65.1M	130.0M	152.0M	96.6M	168.0M	148.0M
Total Liabilities	1.1B	831.0M	708.0M	215.0M	212.0M	137.0M	154.0M	172.0M	403.0M	462.0M	461.0M	489.0M	531.0M
Paid In Capital	227.0M	227.0M	227.0M	227.0M	162.0M	108.0M	108.0M	108.0M	81.0M	81.0M	81.0M	81.0M	81.0M
Capital Reserve	563.0M	575.0M	575.0M	575.0M	639.0M	639.0M	639.0M	639.0M	43.3M	43.3M	43.3M	43.3M	43.3M
Surplus Reserve	195.0M	170.0M	148.0M	135.0M	114.0M	95.4M	78.7M	63.0M	47.5M	32.2M	19.9M	10.0M	1.4M
Retained Earnings	1.2B	1.0B	892.0M	832.0M	688.0M	605.0M	483.0M	393.0M	335.0M	237.0M	165.0M	89.5M	9.3M
Minority Equity	32.8M	31.4M	26.8M	19.5M	20.0M	807,100	--	--	--	--	--	--	--
Equity Attributable	2.2B	2.0B	1.8B	1.8B	1.6B	1.4B	1.3B	1.2B	506.0M	394.0M	309.0M	224.0M	135.0M
Total Equity	2.2B	2.0B	1.9B	1.8B	1.6B	1.4B	1.3B	1.2B	506.0M	394.0M	309.0M	224.0M	135.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012
Cash From Sales	1.1B	1.2B	678.0M	933.0M	918.0M	770.0M	650.0M	562.0M	584.0M	523.0M	477.0M	362.0M	362.0M
Tax Refunds Received	20.1M	10.3M	45.7M	13.00	5.0M	--	--	--	--	--	--	--	--
Total Operating Cash Inflow	1.1B	1.2B	742.0M	957.0M	937.0M	776.0M	664.0M	566.0M	592.0M	526.0M	479.0M	364.0M	418.0M
Cash Paid For Goods	547.0M	491.0M	440.0M	433.0M	364.0M	307.0M	328.0M	309.0M	273.0M	201.0M	182.0M	194.0M	152.0M
Cash Paid To Employees	213.0M	195.0M	191.0M	165.0M	150.0M	141.0M	128.0M	123.0M	102.0M	91.7M	79.1M	66.4M	55.5M
Taxes Paid	105.0M	82.5M	62.0M	71.2M	77.2M	73.3M	59.9M	58.0M	57.3M	51.7M	54.2M	45.1M	55.7M
Total Operating Cash Outflow	931.0M	830.0M	741.0M	710.0M	633.0M	590.0M	565.0M	538.0M	465.0M	376.0M	345.0M	343.0M	302.0M
Operating Cash Flow	178.0M	398.0M	1.2M	247.0M	304.0M	186.0M	99.5M	28.6M	126.0M	150.0M	134.0M	20.9M	116.0M
Total Investing Cash Inflow	22.3M	73,400	21.2M	230,100	605,300	2.3M	4.7M	796,700	4.6M	3.9M	7.2M	7.7M	41.6M
Total Investing Cash Outflow	261.0M	352.0M	508.0M	290.0M	203.0M	103.0M	84.5M	61.4M	59.9M	85.9M	38.4M	56.9M	173.0M
Investing Cash Flow	-238.0M	-352.0M	-487.0M	-290.0M	-203.0M	-101.0M	-79.9M	-60.6M	-55.3M	-81.9M	-31.2M	-49.2M	-131.0M
Cash From Borrowings	253.0M	180.0M	528.0M	75.0M	260.0M	--	60.0M	252.0M	249.0M	357.0M	342.0M	315.0M	355.0M
Dividends And Interest Paid	65.9M	65.6M	57.7M	41.8M	35.7M	32.5M	57.3M	94.0M	58.8M	69.4M	37.3M	126.0M	110.0M
Debt Repayments	91.8M	201.0M	25.0M	132.0M	178.0M	29.0M	101.0M	477.0M	318.0M	349.0M	365.0M	231.0M	200.0M
Total Financing Cash Inflow	253.0M	180.0M	532.0M	79.0M	280.0M	21.2M	60.0M	886.0M	267.0M	357.0M	342.0M	315.0M	355.0M
Total Financing Cash Outflow	169.0M	268.0M	84.1M	175.0M	214.0M	61.5M	158.0M	577.0M	377.0M	437.0M	402.0M	356.0M	310.0M
Financing Cash Flow	83.7M	-88.2M	448.0M	-96.2M	65.5M	-40.3M	-98.3M	309.0M	-110.0M	-80.5M	-59.8M	-41.3M	44.6M
Net Change In Cash	23.3M	-42.4M	-38.2M	-139.0M	167.0M	44.7M	-78.7M	277.0M	-39.3M	-12.3M	43.2M	-69.6M	29.1M
Ending Cash Balance	275.0M	251.0M	294.0M	332.0M	471.0M	304.0M	260.0M	338.0M	61.3M	101.0M	113.0M	69.8M	139.0M
Capex	256.0M	329.0M	327.0M	241.0M	189.0M	77.8M	84.5M	61.4M	59.9M	85.9M	38.4M	56.9M	173.0M